What is CVE-2017-17678?

CVE-2017-17678 is a medium-severity vulnerability in Bmc Remedy Mid-Tier, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2021-05-19.

How severe is CVE-2017-17678?

Medium severity. CVSS v3 base score is 6.1 out of 10.

XSS in Bmc Remedy Mid-Tier

CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Vulnerability class: XSS (Cross-Site Scripting)

Published 2021-05-19 · last modified 2026-07-09.

CVSS v3 metric

CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.

EPSS exploit prediction

EPSS: 0.006 (46.2th percentile), scored 2026-10-01.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 46th percentile — 46.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000

Affected products

Bmc Remedy Mid-Tier — versions 9.1

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

af854a3a-2127-422b-91ae-364da2661108 (Product)
af854a3a-2127-422b-91ae-364da2661108 (Product)
docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security… (Release Notes, Vendor Advisory)
seclists.org/fulldisclosure/2017/Oct/52 (Mailing List, Third Party Advisory)

Frequently asked questions

What is CVE-2017-17678?: CVE-2017-17678 is a medium-severity vulnerability in Bmc Remedy Mid-Tier, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2021-05-19.
How severe is CVE-2017-17678?: Medium severity. CVSS v3 base score is 6.1 out of 10.